PETQ PetIQ Inc. Class A

PetIQ, Inc.’s New SENTRY® Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond

PetIQ, Inc.’s New SENTRY® Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond

Portable Calming Diffuser Uses Scientifically Proven Pheromone Technology To Help Pets Lead Happier, Less Stressful Lives

EAGLE, Idaho, Dec. 20, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, has announced the launch of the Portable Calming Diffuser for Dogs and Cats from its SENTRY® Calming line of pet care products just in time to help pets feel calm and relaxed during the holiday season and beyond.

The portable diffuser uses SENTRY’s® patented pheromone, which has been scientifically proven to help calm pets by lowering their heart rate. The easy-to-use portable diffuser lasts up to 30 days and calms pets by releasing the pheromone into the air with no electricity needed. Pets benefit the most when the diffuser is placed where pets frequent (i.e., social areas, sleeping or resting places), and the desired location has good air flow. When the pheromone cartridge in the diffuser is empty, pet parents can simply replace the used diffuser cartridge with a new pheromone cartridge.

“With the holiday season upon us, now is the time to be thinking of how to help your pets feel calm and safe from loud noises, large crowds, and unfamiliar situations,” said John Pearson, PetIQ’s Executive Vice President, Services and Manufactured Products. “By helping to reduce stress-related issues, like chewing, marking and barking with dogs, or scratching, marking and meowing with cats, all pet parents can feel secure knowing that SENTRY® Portable Calming Diffuser uses safe and scientifically proven technology.”

While traditional diffuser devices often require electricity and an outlet to operate, the SENTRY® Portable Calming Diffuser’s portability allows pet parents the flexibility to use the diffuser throughout their home or anywhere they travel with their pets.

SENTRY® Portable Calming Dog and Cat Diffusers with Base MSRP for $21.99 with refill packs offered in a two-pack for $19.99. On average, the SENTRY® Portable Calming Diffuser provides pet parents with an 11% savings over other leading diffusers on the market today. They are now available on .

For more information about the new SENTRY® Portable Calming Diffuser for Dogs and Cats or other calming solutions including ointment, sprays, chewables, collars, toys and more, please visit: . For more information about PetIQ’s wellness centers and family of pet wellness and vet-approved products including, Minties, PetArmor, NextStar, Capstar, Rocco & Roxie Supply Co., VetIQ supplements and more, please visit .

About PetIQ:

PetIQ is a leading pet medication and wellness company delivering a smarter way for pet parents to help their pets live their best lives through convenient access to affordable veterinary products and services. The Company engages with customers through more than 60,000 points of distribution across retail and e-commerce channels with its branded and distributed medications as well as health and wellness items, which are further supported by its world-class medications manufacturing facility in Omaha, Nebraska and health and wellness manufacturing facility in Springville, Utah. The Company’s national service platform operates in over 2,600 retail partner locations in 41 states providing cost effective and convenient veterinary wellness services. PetIQ believes that pets are an important part of the family and deserve the best products and care we can give them.

PR Contacts:

PetIQ Corporate: or 407.929.6727

PetIQ Consumer: or 917.660.6359 

Photos accompanying this announcement are available at



EN
20/12/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetIQ Inc. Class A

 PRESS RELEASE

PetIQ Names Camillo Pane as Chief Executive Officer

PetIQ Names Camillo Pane as Chief Executive Officer Accomplished Consumer Goods and Health Care LeaderWould Bring Decades of Leadership Experience to Role EAGLE, Idaho, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”), a leading pet medication, health and wellness company and portfolio company of Bansk Group, is pleased to announce that Camillo Pane would join PetIQ as Chief Executive Officer, effective February 17, 2025. Mr. Pane would succeed Cord Christensen. Mr. Pane’s passion for making a difference in the lives of consumers has been a constant focus through...

 PRESS RELEASE

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Gr...

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion. PetIQ stockholders will receive $31.00 in cash per PetIQ share in accordance with the terms of the tran...

 PRESS RELEASE

PetIQ, Inc. Announces Results of Special Meeting of Stockholders

PetIQ, Inc. Announces Results of Special Meeting of Stockholders Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 EAGLE, Idaho, Oct. 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, announced today that at its virtual Special Meeting of Stockholders approximately 80% of its outstanding shares of common stock voted to approve the adoption of the definitive merger agreement (the “Agreement”) pursuant to which Bansk Group will acquir...

 PRESS RELEASE

PetIQ, Inc. Reports Second Quarter 2024 Financial Results

PetIQ, Inc. Reports Second Quarter 2024 Financial Results Generates Record Second Quarter 2024 Net Sales and Net IncomeRecord Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 GuidancePetIQ and Bansk Group Sign Definitive Merger Agreement EAGLE, Idaho, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today reported financial results for the second quarter and six months ended June 30, 2024. Cord Christensen, PetIQ’s Founder and CEO, commented, “We are ...

 PRESS RELEASE

PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk G...

PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk Group PetIQ Stockholders to Receive $31.00 Per Share in an All-Cash Transaction Valued at Approximately $1.5 Billion EAGLE, Idaho, and NEW YORK, New York, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, and Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, today announced that PetIQ entered into a definitive agreement (the “Agreement”) pursuant to which Bansk...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch